ArticleEuropean journal of preventive cardiology2026
Visceral adipose tissue, aortic distensibility and atherosclerotic cardiovascular risk across body mass index categories.
Article in European journal of preventive cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Visceral adiposity, aortic stiffness, and cardiovascular risk.European journal of preventive cardiology · 2026Article
- The application of explainable machine learning for the identification of MASLD in non-obese populations.Frontiers in public health · 2026Article
- Association between triglyceride-glucose index-a body shape index and atherosclerotic cardiovascular disease, and the modification effect of dietary patterns.Frontiers in nutrition · 2026Article
- Association between estimated glucose disposal rate and the risk of atherosclerotic cardiovascular disease: insight from cross-sectional and retrospective cohort studies.Frontiers in nutrition · 2025Article
- Relationship Between Monocyte-to-High-Density Lipoprotein Cholesterol Ratio and Visceral Obesity in Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.Diabetes, metabolic syndrome and obesity : targets and therapy · 2025Article
Corrections and comments
- Commented on by
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
aimsWhile obesity is a well-established risk factor for cardiovascular disease, the relationship between visceral obesity, as assessed by imaging modalities of visceral adipose tissue (VAT), and the risk of atherosclerotic cardiovascular disease (ASCVD) has been insufficiently explored in large-scale studies, particularly across different body mass index (BMI) categories. We aimed at investigating the association between VAT and aortic distensibility as well as risk of ASCVD and comparing the magnitude of VAT-aortic distensibility and VAT-ASCVD association across BMI groups. METHODS AND
resultsLeveraging data from the UK Biobank, we examined the association between body weight-normalized VAT (VAT-index, VATi), assessed via abdominal MRI (VATi-MRI) or dual-energy X-ray absorptiometry (DXA; VATi-DXA), and aortic distensibility (a direct local measure of aortic stiffness) as well as the risk of ASCVD over a median follow-up period of 4.7 years. The abdominal MRI sub-cohort of the UK Biobank included 36 829 individuals, among whom 28 888 individuals were additionally evaluated using DXA. VATi was associated with a decrease in ascending aortic distensibility [VATi-MRI adjusted beta = -0.05 (95% CI: -0.07 to -0.04, P < 0.001)]; [VATi-DXA adjusted beta = -0.04 (95% CI: -0.06 to -0.03, P < 0.001)] and increased risk of ASCVD [VATi-MRI: HR 1.16 (95% CI: 1.09-1.23, P < 0.001)]; [VATi-DXA: 1.21 (95% CI: 1.13-1.3), P < 0.001], adjusted for age, sex, socioeconomic status, lifestyle factors, and cardiometabolic comorbidities. Across BMI categories, these associations were more pronounced in non-obese individuals. The cumulative incidence of ASCVD was higher in individuals with high VATi compared with those with low VATi, consistently observed across BMI categories. With a total of 1461 ASCVD events, incidence rates were higher in individuals with high VATi-MRI (VATi-DXA) compared with low VATi across all BMI categories: 5.3% (5.5%) vs. 2.2% (2.2%) in the normal BMI group, 5.5% (5.7%) vs. 2.5% (2.4%) in the overweight group, and 5.7% (5.9%) vs. 2.1% (2.1%) in the obese group (P log-rank <0.001). Overall, in the multivariable-adjusted Cox proportional hazard model, VATi was associated with increased ASCVD risk, but this association was attenuated when adjusted for the clinical marker of central obesity, the waist-to-hip ratio (WHR). In contrast, the association remained significant in the normal BMI group even after adjusting for WHR [HR for VATi-MRI 1.22 (95% CI: 1.06-1.42, P < 0.01); VATi-DXA 1.35 (95% CI: 1.11-1.65, P < 0.01)].
conclusionVisceral obesity, measured by advanced imaging modalities, is linked to greater aortic stiffness and elevated risk of ASCVD, independent of BMI, in individuals without known ASCVD. Notably, these associations were observed mostly in non-obese subjects, with the strongest associations found in the normal BMI group. These findings highlight the additional predictive value of visceral obesity over general measures like BMI or WHR, particularly among non-obese individuals.
Indexed as
Identifiers
40680099What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.